Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Targeting NNMT to Combat Obesity. Nature Medicine, News & Views coverage of primary research
Stimulates Lipolysis Prompts fat cells to break stored triglycerides into free fatty acids the body can burn for fuel Inhibits Lipogenesis Slows the creation of new fat, working both sides of the fat-storage equation No IGF-1 Rise Isolates the fat-metabolism fragment, so it does not raise IGF-1 or drive tissue growth No Glucose Disruption In studies it did not impair insulin sensitivity or affect blood sugar the way full GH can In laboratory and animal work, the fragment behaved as designed
Tesamorelin Peptide therapy is most suitable for adults struggling with visceral fat that does not respond to conventional weight loss methods
Care is designed to support metabolic, neurological, and gastrointestinal function without overstimulation
Women with previous unsuccessful diet attempts showed particularly strong responses, with 68% achieving clinically significant weight loss (greater than 5% of baseline body weight) compared to 12% in the placebo group
US$ 25.20
US$ 21.99
US$ 26.00
US$ 27.46
